Abstract
Here, we report that glucagon-like peptide-1 analogue liraglutide could enhance survival of human bone marrow-derived mesenchymal stem cells (hMSCs) following co-delivery in fibrin gel matrix. The hMSCs were treated with various concentrations (≤100 nM) of liraglutide. After 48 h, 100 nM liraglutide-treated hMSCs showed 1.4-fold higher cell viability than untreated hMSCs. Calcein staining for live cells and trypan blue staining for dead cells provided visual evidences that treatment of hMSCs with liraglutide increased cell survival. To evaluate the cell survival of hMSCs after in vivo transplantation, genomic DNA of hMSCs was quantified by quantitative real-time polymerase chain reaction by detecting human Alu element. Four days after transplantation, the survival of hMSCs co-transplanted with liraglutide (1.9 μg/kg) was 7.7-fold higher than that of plain hMSCs formulation. Taken together, our findings suggest the potential of liraglutide as a transplantation adjuvant for increasing in vivo survival of hMSCs.
Similar content being viewed by others
References
Ade C, Roy-Engel AM, Deininger PL (2013) Alu elements: an intrinsic source of human genome instability. Curr Opin Virol 3:639–645
Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L (2009) Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26 week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374:39–47
Calarco A, Petillo O, Bosetti M, Torpedine A, Cannas M, Perrone L, Galderisi U, Melone MAB, Peluso G (2010) Controlled delivery of the heparan sulfate/FGF-2 complex by a polyelectrolyte scaffold promotes maximal hMSC proliferation and differentiation. J Cell Biochem 110:903–909
Cheng K, Gupta S (2009) Quantitative tools for assessing the fate of xenotransplanted human stem/progenitor cells in chimeric mice. Xenotransplantation 16:145–151
Churro C, Pereira P, Vasconcelos V, Valério E (2012) Species-specific real-time PCR cell number quantification of the bloom-forming cyanobacterium Planktothrix agardhii. Arch Microbiol 194:749–757
Croom K, McCormack P (2009) Liraglutide. Drugs 69:1985–2004
Das R, Jahr H, van Osch GJ, Farrell E (2010) The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev 16:159–168
Gu E, Chen WY, Gu J, Burridge P, Wu JC (2012) Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics 2:335–345
Gupta V (2013) Glucagon-like peptide-1 analogues: an overview. Indian J Endocrinol Metab 17:413–421
Han W-N, Hölscher C, Yuan L, Yang W, Wang X-H, Wu M-N, Qi J-S (2011) Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats. Neurobiol Aging 34:576–588
Haque N, Rahman MT, Abu Kasim NH, Alabsi AM (2013) Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. Sci World J 2013:632972
Huang B, Qian J, Ma J, Huang Z, Shen Y, Chen X, Sun A, Ge J, Chen H (2014) Myocardial transfection of hypoxia-inducible factor-1 alpha and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther 5:22
Li Z, Ni C-L, Yao Z, Chen L-M, Niu W-Y (2014) Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells. Metabolism 63:1022–1030
Lund A, Knop FK, Vilsbøll T (2014) Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities. Eur J Intern Med 25:407–414
Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA (2007) In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25:220–227
Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20:1297–1308
Ramot Y, Meiron M, Toren A, Steiner M, Nyska A (2009) Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery. Toxicol Pathol 37:606–616
Shao S, Nie M, Chen C, Chen X, Zhang M, Yuan G, Yu X, Yang Y (2014) Protective action of liraglutide in beta cells under lipotoxic stress via PI3 K/Akt/FoxO1 pathway. J Cell Biochem 115:1166–1175
Sharma MK, Jalewa J, Hölscher C (2014a) Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress. J Neurochem 128:459–471
Sharma RR, Pollock K, Hubel A, McKenna D (2014b) Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54:1418–1437
Shim G, Im S, Lee S, Park JY, Kim J, Jin H, Lee S, Im I, Kim D-D, Kim SW, Lee TJ, Eom JS, Yi T-G, Song SU, Byun Y, Oh Y-K (2013) Enhanced survival of transplanted human adipose-derived stem cells by co-delivery with liposomal apoptosome inhibitor in fibrin gel matrix. Eur J Pharm Biopharm 85:673–681
Spender LC, Inman GJ (2012) Phosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt’s lymphoma cells to BH3 mimetics. Mol Cancer Res 10:347–359
Toupet K, Maumus M, Peyrafitte J-A, Bourin P, van Lent PLEM, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D (2013) Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. Arthritis Rheum 65:1786–1794
Wang Y, Li C, Cheng K, Zhang R, Narsinh K, Li S, Li X, Qin X, Su T, Chen J, Cao F (2014) Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells (AD-MSCs) to attenuate myocardial ischemia injury through TLR4/NF-kappaB and Keap-1/Nrf2 signaling pathways. Antioxid Redox Signal. doi:10.1089/ars.2013.5683
Yi T, Lee HJ, Cho YK, Jeon MS, Song SU (2014) Molecular characterization of neurally differentiated human bone marrow-derived clonal mesenchymal stem cells. Immune Netw 14:54–65
Yoo HS, Yi T, Cho YK, Kim WC, Song SU, Jeon MS (2013) Mesenchymal stem cell lines isolated by different isolation methods show variations in the regulation of graft-versus-host disease. Immune Netw 13:133–140
Acknowledgments
All authors (H. Jin, W. J. Lee, S. Lee, T. Yi, S. U. Song, G. Shim, Y.-K. Oh) declare that they have no conflict of interest. This work was supported by research grants from the Ministry of Science, ICT and Future Planning (NRF-2012R1A2A1A01007005), from the Korean Health Technology R&D Project (A092010), and from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A01026829).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jin, H., Lee, W.J., Lee, S. et al. Enhanced survival of human mesenchymal stem cells following co-delivery with glucagon-like peptide-1 analogue in fibrin gel. Journal of Pharmaceutical Investigation 45, 143–149 (2015). https://doi.org/10.1007/s40005-014-0156-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-014-0156-x